Category: Health & Medicines > Medicines > Pharmaceutical Drug
Country/Region: China
Main Products: API, Intermediates, Apremilast, Rivaroxaban, Canagliflozin, Ticagrelor, Anastrozole, Palonosetronl, API
Business Type: Manufacturer
Business Nature: Manufacturer
Year Established: 2007, 2007
Legal Status: Third Party
Ownership: Professional Association
Employees: 101 - 200 People
Factory Size: 5, 000-10, 000 square meters
R&D Team Size: 51 - 100 People
Certifications: ISO17025
Contact Person: wendy czhu
Designation: Board Chairman/CEO
Department: Director/CEO/General Manager
Telephone: 86-15321296850
Main Markets: India (29%) Canada (21%) Saudi Arabia (16%) South Korea (12%) Australia (10%)
Export Focus: Australia, Canada, India, South Korea, Saudi Arabia
Contract Services: Buyer Label Offered
Annual Revenue: More than 6 Million US Dollar
Registered Capital: US$10 Million - US$50 Million
Export Percentage: 61% - 70%
Payment Terms: Bank wire (T/T), MoneyGram, Credit Card (CC), PayPal